EXPERIMENTAL IMMUNOLOGY
Angiomodulatory properties of some antibiotics and Tołpa Peat Preparation
More details
Hide details
Submission date: 2016-01-28
Acceptance date: 2016-02-03
Publication date: 2016-03-24
Cent Eur J Immunol 2016;41(1):19-24
KEYWORDS
ABSTRACT
Deterioration of the immune system due to antibiotic therapy can be restored by immunomodulator application. In this paper we estimate the effect of ampicillin, amikacin, doxycycline, rifampicin, rifamycine and immunomodulator Tołpa Peat Preparation (TPP) on neovascular reaction induced in murine skin by human mononuclear cells (MNC) injection. MNC originating from 15 healthy volunteers were injected intradermally to Balb/c mice. Antibiotics (3, 15, or 75 mg/kg of body weight) alone or with TPP (10 mg/kg of body weight) were administrated subcutaneously to mice on three consecutive days. The number of newly formed blood vessels was measured in dissection microscope 72 hours after cell injection. Results: TPP stimulated angiogenic activity of MNC at the dose 5 and 10 mg/kg. Rifamycine exerted strong stimulatory action, ampicillin slightly stimulated immune response, while doxycycline and rifampicin downregulated it. Amikacin did not influence the results of angiogenesis tests. Studied antibiotics (15 mg/kg), except rifamycine, inhibit the angiostimulatory effect of the tested immunomodulator. TPP should be applied after antibiotic therapy to maintain its stimulatory effect and restore proper host immune function.
REFERENCES (28)
1.
Radomska D (1994): Antybiotyki a układ odpornościowy. Reumatologia 32: 63-68.
2.
Radomska-Leśniewska DM, Skopiński P, Bałan BJ, et al. (2015): Angiomodulatory properties of Rhodiola spp. and other natural antioxidants. Cent Eur J Immunol 40: 249-262.
3.
Tołpa S (1992): The history of the discovery and development of investigation on Tołpa Torf preparation. In: Preclinical investigation of Tołpa Torf Preparation (TPP). Danysz A (ed.) Torf Corporation, Wrocław.
4.
Inglot A, Zielińska-Jenczylik J, Sypuła J (1993): A method to asses the immunomodulating effects of the Tołpa Torf Preparation (TTP) by measuring the hyporeactivity to interferon induction and tumor necrosis factor response. Arch Immunol Ther Exp 41: 87-93.
5.
Inglot AD, Sobiech KA, Zielinska-Jenczylik J, et al. (1999): Development and disappearance of tolerance to induction of interferon and tumor necrosis factor response in athletes treated with natural immunostimulant. Arch Immunol Ther Exp (Warsz) 47: 237-244.
6.
Skopińska-Różewska E, Polakowski I, Żukowska M, et al. (1993): The effect of Tołpa Peat Preparation (TPP) on human mononuclear leucocytes induced angiogenesis. Herba Polonica 39: 41-51.
7.
Krzemiński TF, Nożyński JK, Grzyb J, et al. (2005): Angiogenesis and cardioprotection after TNF-inducer-Tołpa Peat Preparation treatment in rat’s hearts after experimental myocardial infarction in vivo. Vascul Pharmacol 43: 164-170.
8.
Wollina U (2009): Peat: A natural source for dermatocosmetics and dermatotherapeutics. J Cutan Aesthet Surg 2: 17-20.
9.
Radomska-Leśniewska DM, Skopińska-Różewska E, Malejczyk J (2010): The effect of clindamycin and lincomycin on angiogenic activity of human blood mononuclear cells. Centr Eur J Immunol 35: 217-222.
10.
Boyum A (1968): Isolation of mononuclear cells by one centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 97: 77-89.
11.
Sidky YA, Auerbach R (1975): Lymphocyte-induced angiogenesis: a quantitative and sensitive assay for the graft versus-host reaction. J Exp Med 141: 1084-1100.
12.
Skopińska-Różewska E, Sommer E, Demkow U, et al. (1997): Screening of angiogenesis inhibitors by modified TIA test in lung cancer. Annales Acad Med Bialostocensis 42 (Suppl 1): 287-296.
13.
Pomorska-Mól M, Pejsa Z (2012): Effects of antibiotics on acquired immunity in vivo – current state of knowledge. Pol J Vet Sci 15: 583-588.
14.
Radomska-Leśniewska D, Skopińska-Różewska E, Jankowska-Steifer E (2010): The effect of selected cephalosporins on angiogenic activity of human blood mononuclear cells. Centr Eur J Immunol 35: 14-19.
15.
Rogala E, Skopińska-Różewska E, Bałan B, et al. (2001): The influence of cefoperazon on angiogenesis induced by homogenates of BAL cells obtained from sarcoidosis patients. Terapia 3: 18-20.
16.
Skopińska-Różewska E, Nowaczyk M, Lao M, Górski AJ (1981): The effect of ampicillin on the expression of Fc-IgG receptors on human peripheral blood lymphocytes. Biomedicine 35: 41-42.
17.
Skopińska-Różewska E, Kamiński M, Nowaczyk M, et al. (1985): Immunomodulatory action of ampicillin. Folia Biol (Praha) 31: 200-212.
18.
Włodarska B, Bany J, Marczak M, et al. (1987): Altered immune reactivity of mice born from mothers treated with ampicillin during gestation. Folia Biol (Praha) 33: 210-215.
19.
Artsimowich NG, Nastoiashchaia NN, Mul`tanowskaia VN, et al. (1991): Izuchenie immunotropnoi aktiwnosti antibiotikow iz grupy aminoglikozidow. Antibiot-Khimioter 36: 27-29.
20.
Villa ML, Radppocido G, Piazza P, et al. (1986): The interference with antibiotics with antigen-specific antibody responses in man. Int J Immunopharmacol 8: 805-809.
21.
Roszkowski W, Ko HL, Roszkowski K, et al. (1985): Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin, clindamycin. Med Mikrobiol Immunol 173: 279-289.
22.
Forsgren A, Gnarpe H (1973): Tetracyclines and host – defense mechanism. Antimicrob Agents Chemother 6: 711-715.
23.
Amurio T, Lewden S, Nicolas R, et al. (1982): Effect of treatment with clindamycin, erythromycin, rifamycin, or gentamycin on the ingestion capacity of peritoneal macrophages in mice. Pathol Biol Paris 38: 13-18.
24.
Amagai T, Matsuzawa T, Cinaber B (1990): The effect of ribavirin and rifamycin SV on age-dependent changes of the immnune system during the adult life of SJ 1 mice. Immunol Lett 4: 149-153.
25.
Demkow U, Radomska D, Chorostowska-Wynimko J, Skopińska-Różewska E (1998): Wpływ ryfampicyny na wybrane parametry odpowiedzi immunologicznej. Pneumonol Alergol Pol 66: 45-53.
26.
Bellahsene A, Forsgen A (1980): Effect of rifampin on the immune response in mice. Infect Immun 27: 15-20.
27.
Bassi L, di Bernardino L, Perna G (1979): Lack of effect of rifampin on the antibody response to a viral antigen in patients with tuberculosis. Am Rev Resp Dis 112: 739-741.
28.
Radomska-Leśniewska D, Demkow U, Sokolnicka I, Chorostowska-Wynimko J: Interakcje antybiotyków i immunomodulatorów w angiogenezie immunologicznej. Terapia 2001; 3: 10-11.